X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Stock Has Average Price Target of $11.25 According to Brokerages
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Sat, 10 October 2026
What it is about
John VolponeDavid KirskeWells Fargo CompanyPharmaceuticals SecuresSecurities Exchange CommissionNasdaqPharmaceuticals Stock Rated ModeratePharmaceuticals DailyPharmaceuticals Investor DayDrug AdministrationPharmaceuticals Price PerformanceAmerica CorpSquarepoint OpsPerceptive AdvisorsYork Mellon CorpAmerica
Who published it, and when
How it spread - 1 original report
Sat, 10 October 2026
1 report- dailypolitical.com22:28first to report
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the […]